The DOI matches its Crossref record; 235 of the 235 references it cites were found in a registry or an index.
Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis
Open accessAbstract
Transitions between epithelial and mesenchymal phenotypes - the epithelial to -mesenchymal transition (EMT) and its reverse the mesenchymal to epithelial transition (MET) - are hallmarks of cancer metastasis. While transitioning between the epithelial and mesenchymal phenotypes, cells can also attain a hybrid epithelial/mesenchymal (E/M) (i.e., partial or intermediate EMT) phenotype. Cells in this phenotype have mixed epithelial (e.g., adhesion) and mesenchymal (e.g., migration) properties, thereby allowing them to move collectively as clusters. If these clusters reach the bloodstream intact, they can give rise to clusters of circulating tumor cells (CTCs), as have often been seen experimentally. Here, we review the operating principles of the core regulatory network for EMT/MET that acts as a "three-way" switch giving rise to three distinct phenotypes - E, M and hybrid E/M - and present a theoretical framework that can elucidate the role of many other players in regulating epithelial plasticity. Furthermore, we highlight recent studies on partial EMT and its association with drug resistance and tumor-initiating potential; and discuss how cell-cell communication between cells in a partial EMT phenotype can enable the formation of clusters of CTCs. These clusters can be more apoptosis-resistant and have more tumor-initiating potential than singly moving CTCs with a wholly mesenchymal (complete EMT) phenotype. Also, more such clusters can be formed under inflammatory conditions that are often generated by various therapies. Finally, we discuss the multiple advantages that the partial EMT or hybrid E/M phenotype have as compared to a complete EMT phenotype and argue that these collectively migrating cells are the primary "bad actors" of metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–235 of 235
Cutaneous Wound Reepithelialization: A Partial and Reversible EMT
Arnoux, V., Côme, C., Kusewitt, D. F., Hudson, L. G., & Savagner, P. (2005) · Springer eBooks · doi:10.1007/0-387-28671-3_8 · Cited by 62
EMT or EMT-Promoting Transcription Factors, Where to Focus the Light?
Ansieau, S., Collin, G., & Hill, L. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00353 · Cited by 62
Toward Decoding the Principles of Cancer Metastasis Circuits
Lu, M., Jolly, M. K., Onuchic, J. N., & Ben‐Jacob, E. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3367 · Cited by 58
Self-citationBastos, L. G., de Marcondes, P. G., de‐Freitas‐Junior, J. C. M., Leve, F., Mencalha, A. L., de Souza, W. F., de Araújo, W. M., Tanaka, M. N., Abdelhay, E. S. F. W., & Morgado‐Díaz, J. A. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24896 · Cited by 57
Epithelial-to-Mesenchymal Plasticity Harnesses Endocytic Circuitries
Corallino, S., Malabarba, M. G., Zobel, M., Fiore, P. P. D., & Scita, G. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00045 · Cited by 57
Schuetz, A. N., Rubin, B. P., Goldblum, J. R., Shehata, B. M., Weiss, S. W., Liu, W. J., Wick, M. R., & Folpe, A. L. (2005) · Modern Pathology · doi:10.1038/modpathol.3800435 · Cited by 57
Cooperation, amplification, and feed-back in epithelial–mesenchymal transition
de Herreros, A. G., & Baulida, J. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.01.003 · Cited by 56
Correlation of Notch1, pAKT and nuclear NF-κB expression in triple negative breast cancer.
Zhu, H., Bhaijee, F., Ishaq, N. Y., Pepper, D. J., Backus, K. V., Brown, A. S., Zhou, X., & Miele, L. (2013) · Europe PMC (PubMed Central) · Cited by 54
Tumor Plasticity Interferes with Anti-Tumor Immunity
Chouaïb, S., Janji, B., Tittarelli, A., Eggermont, A. M. M., & Thiery, J. P. (2014) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2014010183 · Cited by 54
Target-Specific and Global Effectors in Gene Regulation by MicroRNA
Levine, E., Jacob, E. B., & Levine, H. (2007) · Biophysical Journal · doi:10.1529/biophysj.107.118448 · Cited by 54
Futterman, M., Garcı́a, A. J., & Zamir, E. A. (2011) · Developmental Dynamics · doi:10.1002/dvdy.22607 · Cited by 54
Tumor Invasion Optimization by Mesenchymal-Amoeboid Heterogeneity
Hecht, I., El, Y. B., Balmer, F., Natan, S., Tsarfaty, I., Schweitzer, F., & Ben‐Jacob, E. (2015) · Scientific Reports · doi:10.1038/srep10622 · Cited by 53
Operating principles of Notch–Delta–Jagged module of cell–cell communication
Jolly, M. K., Boareto, M., Lu, M., Onuchic, J. N., Clementi, C., & Ben‐Jacob, E. (2015) · New Journal of Physics · doi:10.1088/1367-2630/17/5/055021 · Cited by 52
Self-citationAndrecut, M., Halley, J. D., Winkler, D. A., & Huang, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019358 · Cited by 52
Cancer treatments transform residual cancer cell phenotype
Harless, W. W. (2011) · Cancer Cell International · doi:10.1186/1475-2867-11-1 · Cited by 52
Yang, K. R., Mooney, S. M., Zarif, J. C., Coffey, D. S., Taichman, R. S., & Pienta, K. J. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24813 · Cited by 50
Nair, M., Bilanchone, V., Ortt, K., Sinha, S., & Dai, X. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl1141 · Cited by 45
Why are cellular switches Boolean? General conditions for multistable genetic circuits
Macía, J., Stefanie Widder, A., & Solé, R. V. (2009) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2009.07.019 · Cited by 42
Incomplete expression of epithelial–mesenchymal transition markers in idiopathic pulmonary fibrosis
Morbini, P., Inghilleri, S., Campo, I., Oggionni, T., Zorzetto, M., & Luisetti, M. (2011) · Pathology - Research and Practice · doi:10.1016/j.prp.2011.06.006 · Cited by 42
Regulation of Stem Cell Plasticity: Mechanisms and Relevance to Tissue Biology and Cancer
Strauss, R., Hamerlik, P., Lieber, A., & Bartek, J. (2012) · Molecular Therapy · doi:10.1038/mt.2012.2 · Cited by 41
Mechanisms generating bistability and oscillations in microRNA-mediated motifs
Zhou, P., Cai, S., Liu, Z., & Wang, R. (2012) · Physical Review E · doi:10.1103/physreve.85.041916 · Cited by 37
Evidence for a common progenitor of epithelial and mesenchymal components of the liver
Conigliaro, A., Amicone, L., Costa, V., Puzzonia, M. D. S., Mancone, C., Sacchetti, B., Cicchini, C., Garibaldi, F., Brenner, D. A., Kisseleva, T., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.49 · Cited by 33
Johnen, N., Francart, M., Thelen, N., Cloes, M., & Thiry, M. (2012) · Histochemistry and Cell Biology · doi:10.1007/s00418-012-0969-5 · Cited by 31
Enderling, H., Hahnfeldt, P., Hlatky, L., & Almog, N. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3269 · Cited by 28
Nyayanit, D. A., & Gadgil, C. J. (2015) · RNA · doi:10.1261/rna.046862.114 · Cited by 27
Epithelial plasticity in prostate cancer: principles and clinical perspectives
Das, R., Gregory, P. A., Hollier, B. G., Tilley, W. D., & Selth, L. A. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.09.004 · Cited by 25
Non-genetic heterogeneity, criticality and cell differentiation
Pal, M., Ghosh, S., & Bose, I. (2014) · Physical Biology · doi:10.1088/1478-3975/12/1/016001 · Cited by 24
Formalizing an Integrative, Multidisciplinary Cancer Therapy Discovery Workflow
McGuire, M. F., Enderling, H., Wallace, D. I., Batra, J. S., Jordan, M., Kumar, S., Panetta, J. C., & Pasquier, E. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0310 · Cited by 22
Umbreit, C., Flanjak, J., Weiß, C., Erben, P., Aderhold, C., Faber, A., Stern‐Straeter, J., Hoermann, K., & Schultz, J. D. (2014) · PubMed · Cited by 20
Cai, X., Dai, Z., Reeves, R. S., Caballero-Benitez, A., Duran, K. L., Delrow, J. J., Porter, P. L., Spies, T. A., & Groh, V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108942 · Cited by 19
Reprogramming cell fate: a changing story
Chin, M. T. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00046 · Cited by 18
Reinforcing targeted therapeutics with phenotypic stability factors
Yaswen, P. (2014) · Cell Cycle · doi:10.4161/15384101.2014.985071 · Cited by 18
Roca, H., Pande, M., Huo, J. S., Hernandez, J. R., Cavalcoli, J. D., Pienta, K. J., & McEachin, R. C. (2014) · BMC Systems Biology · doi:10.1186/1752-0509-8-29 · Cited by 17
Epithelial to mesenchymal transition in tumor cells as consequence of phenotypic instability
de Herreros, A. G. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00071 · Cited by 13
Regulation of human breast stem cells
Clarke, R. B. (2006) · Breast Cancer Research · doi:10.1186/bcr1550 · Cited by 1
Cited by
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
EMT Transition States during Tumor Progression and Metastasis
Pastushenko, I., & Blanpain, C. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.12.001 · Cited by 2,876
Brabletz, T., Kalluri, R., Nieto, M. A., & Weinberg, R. A. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.118 · Cited by 1,961
Epithelial Mesenchymal Transition in Tumor Metastasis
Mittal, V. (2018) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043854 · Cited by 1,528
Loh, C.-Y., Chai, J., Tang, T., Wong, W., Sethi, G., Shanmugam, M., Chong, P., & Looi, C. (2019) · Cells · doi:10.3390/cells8101118 · Cited by 1,315
Metadata
- Authors
- Jolly, M. K.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2015
- Volume
- 5
- Pages
- 155-155
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W1689351220
- Cited by
- 693
- References
- 235
- FWCI
- 23.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.